Refining the regulatory context of controlled human infection models

This workshop will convene leading researchers, industry experts, regulators, and ethicists to examine the evolving regulatory, ethical, and scientific landscape of Controlled Human Infection Models (CHIMs), with a particular focus on RSV, C. difficile, and influenza trials

| Download  |